174 related articles for article (PubMed ID: 35182225)
1. D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma.
Urla C; Corteletti I; Raible AS; Handgretinger R; Fuchs J; Warmann SW; Schmid E
J Cancer Res Clin Oncol; 2022 Jun; 148(6):1337-1350. PubMed ID: 35182225
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma.
Urla C; Stagno MJ; Fuchs J; Warmann SW; Schmid E
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2513-2522. PubMed ID: 35764701
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.
Regenbogen S; Stagno MJ; Schleicher S; Schilbach K; Bösmüller H; Fuchs J; Schmid E; Seitz G
Int J Oncol; 2020 Jul; 57(1):289-300. PubMed ID: 32377699
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of curcumin in pediatric rhabdomyosarcoma in combination with chemotherapy and phototherapy in vitro.
Sorg C; Schmid E; Bortel N; Fuchs J; Ellerkamp V
Int J Oncol; 2021 Feb; 58(2):266-274. PubMed ID: 33491749
[TBL] [Abstract][Full Text] [Related]
5. Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood rhabdomyosarcoma.
Seitz G; Warmann SW; Vokuhl CO; Heitmann H; Treuner C; Leuschner I; Fuchs J
Pediatr Surg Int; 2007 May; 23(5):431-9. PubMed ID: 17211591
[TBL] [Abstract][Full Text] [Related]
6. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
Cinatl J; Cinatl J; Michaelis M; Kabickova H; Kotchetkov R; Vogel JU; Doerr HW; Klingebiel T; Driever PH
Cancer Res; 2003 Apr; 63(7):1508-14. PubMed ID: 12670897
[TBL] [Abstract][Full Text] [Related]
7. The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo.
Xu N; Hua Z; Ba G; Zhang S; Liu Z; Thiele CJ; Li Z
J Exp Clin Cancer Res; 2019 Mar; 38(1):118. PubMed ID: 30850026
[TBL] [Abstract][Full Text] [Related]
8. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.
Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J
Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.
Heinicke U; Fulda S
Cancer Lett; 2014 Aug; 351(1):50-8. PubMed ID: 24814395
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma.
Friesen C; Hormann I; Roscher M; Fichtner I; Alt A; Hilger R; Debatin KM; Miltner E
Cell Cycle; 2014; 13(10):1560-70. PubMed ID: 24626197
[TBL] [Abstract][Full Text] [Related]
11. Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids.
Fiegl H; Hagenbuchner J; Kyvelidou C; Seeber B; Sopper S; Tsibulak I; Wieser V; Reiser E; Roessler J; Huhtinen K; Carpén O; Parson W; Sprung S; Marth C; Ausserlechner MJ; Zeimet AG
Gynecol Oncol; 2022 Apr; 165(1):129-136. PubMed ID: 35033381
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
Ciarapica R; Carcarino E; Adesso L; De Salvo M; Bracaglia G; Leoncini PP; Dall'agnese A; Verginelli F; Milano GM; Boldrini R; Inserra A; Stifani S; Screpanti I; Marquez VE; Valente S; Mai A; Puri PL; Locatelli F; Palacios D; Rota R
BMC Cancer; 2014 Feb; 14():139. PubMed ID: 24575771
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glutathione-S-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma.
Seitz G; Bonin M; Fuchs J; Poths S; Ruck P; Warmann SW; Armeanu-Ebinger S
Int J Oncol; 2010 Feb; 36(2):491-500. PubMed ID: 20043085
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
15. The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models.
Gidding CE; Germain GS; Dilling MB; Meeuwsen-de Boer TG; Ashmun RA; de Graaf SS; Veverka KA; Kamps WA; Houghton PJ
Cancer Chemother Pharmacol; 2000; 45(1):21-30. PubMed ID: 10647497
[TBL] [Abstract][Full Text] [Related]
16. Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.
Alcon C; Manzano-Muñoz A; Prada E; Mora J; Soriano A; Guillén G; Gallego S; Roma J; Samitier J; Villanueva A; Montero J
Cell Death Dis; 2020 Aug; 11(8):634. PubMed ID: 32801295
[TBL] [Abstract][Full Text] [Related]
17. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
Bharathy N; Berlow NE; Wang E; Abraham J; Settelmeyer TP; Hooper JE; Svalina MN; Bajwa Z; Goros MW; Hernandez BS; Wolff JE; Pal R; Davies AM; Ashok A; Bushby D; Mancini M; Noakes C; Goodwin NC; Ordentlich P; Keck J; Hawkins DS; Rudzinski ER; Mansoor A; Perkins TJ; Vakoc CR; Michalek JE; Keller C
Skelet Muscle; 2019 May; 9(1):12. PubMed ID: 31113472
[TBL] [Abstract][Full Text] [Related]
18. D,L-Methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca
Lee J; Rosales JL; Byun HG; Lee KY
Sci Rep; 2021 Jan; 11(1):1009. PubMed ID: 33441856
[TBL] [Abstract][Full Text] [Related]
19. Cell death sensitization of leukemia cells by opioid receptor activation.
Friesen C; Roscher M; Hormann I; Fichtner I; Alt A; Hilger RA; Debatin KM; Miltner E
Oncotarget; 2013 May; 4(5):677-90. PubMed ID: 23633472
[TBL] [Abstract][Full Text] [Related]
20. Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.
Hedrick E; Crose L; Linardic CM; Safe S
Mol Cancer Ther; 2015 Sep; 14(9):2143-53. PubMed ID: 26162688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
